Constipation Does Not Cause Elevated AST and ALT
Constipation is not a recognized cause of elevated aminotransferases (AST and ALT). When you encounter elevated liver enzymes, you need to systematically evaluate for actual hepatobiliary disease rather than attributing them to gastrointestinal symptoms like constipation.
Understanding What Causes Elevated Aminotransferases
According to current guidelines, elevated AST and ALT indicate hepatocyte injury and necrosis, with enzymes leaking from damaged liver cells into the bloodstream 1. The established causes fall into clear categories:
Common Causes of Mild Elevations (<5x upper limit):
- Nonalcoholic fatty liver disease (NAFLD) - most common in developed countries (20-30% general population, up to 90% with diabetes)
- Alcohol-induced liver disease - typically AST:ALT ratio >2
- Drug-induced liver injury
- Chronic viral hepatitis (B and C)
- Hereditary hemochromatosis 1
Other Hepatic Causes:
- Acute viral hepatitis
- Autoimmune hepatitis
- Ischemic hepatitis
- Budd-Chiari syndrome
- Wilson disease
- Alpha-1 antitrypsin deficiency 1
Critical Non-Hepatic Causes of AST Elevation:
While ALT is specific for liver injury, AST can be elevated from:
- Cardiac muscle damage (myocardial infarction, myocarditis)
- Skeletal muscle damage (rhabdomyolysis, myopathy, strenuous exercise)
- Hemolysis
- Thyroid disease
- Hematologic disorders 1, 2
The Systematic Approach to Elevated Liver Enzymes
When you encounter elevated AST/ALT, follow this algorithmic approach 3:
Obtain detailed history focusing on:
- Alcohol consumption (quantity and pattern)
- All medications including over-the-counter drugs, vitamins, and herbal supplements
- Risk factors for viral hepatitis
- Metabolic syndrome components (obesity, diabetes, dyslipidemia)
- Family history of liver disease
Perform targeted serologic testing:
- Hepatitis B surface antigen (HBsAg) and core antibody
- Hepatitis C antibody
- Iron studies (ferritin, transferrin saturation)
- Consider autoimmune markers if clinically indicated
Assess the pattern:
- Hepatocellular pattern: AST/ALT elevated disproportionately to alkaline phosphatase
- Cholestatic pattern: Alkaline phosphatase elevated disproportionately to aminotransferases
- AST predominance: Consider non-hepatic sources (cardiac, skeletal muscle, hemolysis) 1
Consider imaging:
- Abdominal ultrasound is first-line for detecting steatosis (84.8% sensitivity, 93.6% specificity for moderate-severe fatty infiltration) 1
Common Clinical Pitfall
Do not attribute elevated liver enzymes to benign gastrointestinal symptoms like constipation. This can lead to delayed diagnosis of significant liver disease. One study found that even irritable bowel syndrome (IBS) patients with elevated ALT had higher rates of metabolic syndrome (32.5% vs 12.7%), suggesting the liver enzyme elevation was related to metabolic factors, not the bowel disorder itself 4.
When to Pursue Further Evaluation
The guidelines are clear about when to escalate workup 3:
- Markedly elevated enzymes (>5x upper limit) warrant expeditious evaluation
- Persistent elevation (≥6 months) requires additional serologic/radiologic studies and potentially liver biopsy
- Any evidence of hepatic dysfunction (abnormal albumin, prolonged prothrombin time) or decompensation requires urgent evaluation
The Bottom Line
If your patient has constipation and elevated AST/ALT, investigate the liver enzyme elevation independently using the systematic approach outlined above. The constipation is coincidental, not causative. Focus your diagnostic efforts on identifying the true etiology of hepatocyte injury, which most commonly will be NAFLD, alcohol use, medications, or viral hepatitis 3, 1.